Education
About Us
Working with TipRanks
Follow Us
Biotest (0N6Z) (DE:BIO)
:BIO
BIO Stock Chart & Stats
Day’s Range― - ―
52-Week Range€39.00 - €45.60
Previous CloseN/A
Volume121.00
Average Volume (3M)104.00
Market Cap
€1.40B
Enterprise Value€2.15B
Total Cash (Recent Filing)€119.50M
Total Debt (Recent Filing)€597.20M
Price to Earnings (P/E)64.1
Beta-0.07
Next Earnings
Aug 04, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jul 03, 2025Dividend Yield0.1%
Share Statistics
EPS (TTM)N/A
Shares Outstanding19,785,727
10 Day Avg. Volume24
30 Day Avg. Volume104
Financial Highlights & Ratios
PEG Ratio1.07
Price to Book (P/B)4.56
Price to Sales (P/S)0.00
P/FCF Ratio-24.26
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BIO FAQ
What was Biotest (0N6Z)’s price range in the past 12 months?
Biotest (0N6Z) lowest stock price was €39.00 and its highest was €45.60 in the past 12 months.
What is Biotest (0N6Z)’s market cap?
Biotest (0N6Z)’s market cap is €1.40B.
When is Biotest (0N6Z)’s upcoming earnings report date?
Biotest (0N6Z)’s upcoming earnings report date is Aug 04, 2025 which is in 26 days.
How were Biotest (0N6Z)’s earnings last quarter?
Currently, no data Available
Is Biotest (0N6Z) overvalued?
According to Wall Street analysts Biotest (0N6Z)’s price is currently Overvalued.
Does Biotest (0N6Z) pay dividends?
Biotest (0N6Z) pays a Annually dividend of €0.04 which represents an annual dividend yield of 0.1%. See more information on Biotest (0N6Z) dividends here
What is Biotest (0N6Z)’s EPS estimate?
Biotest (0N6Z)’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biotest (0N6Z) have?
Biotest (0N6Z) has 19,785,727 shares outstanding.
What happened to Biotest (0N6Z)’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Biotest (0N6Z)?
Currently, no hedge funds are holding shares in DE:BIO
Biotest Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-4.17%
12-Months-Change
Fundamentals
Return on Equity
-4.72%
Trailing 12-Months
Asset Growth
-2.09%
Trailing 12-Months
Company Description
Biotest (0N6Z)
Biotest AG is a Germany-based biotechnology company specializing in the development and production of plasma protein therapies and biotherapeutic drugs. The company operates primarily in the healthcare sector, focusing on products for clinical immunology, hematology, and intensive care medicine. Biotest's core products include immunoglobulins, clotting factors, and albumin solutions, which are used in treating various life-threatening diseases and conditions.
Technical Analysis
Evotec
―
Evotec
―
Eckert & Ziegler Strahlen und Medizintechnik
―
Eckert & Ziegler Strahlen und Medizintechnik
―
Medios AG
―
Medios AG
―
Formycon AG
―
Formycon AG
―